![Gabriel Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriel Brooks
Technik-/Wissenschafts-/F&E-Leiter bei
SOLID BIOSCIENCES INC.
Vermögen: 703 052 $ am 30.09.2026
Profil
Gabriel Brooks is Chief Medical Officer at Solid Biosciences, Inc. since 2023.
Formerly, Dr. Brooks was Vice President-Research & Development at 4D Molecular Therapeutics, Inc. from 2018 to 2020.
Education includes undergraduate studies at Carnegie Mellon University, a doctorate from Cornell University, and graduate studies at the University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.10.2026 | 97’241 ( 0.09% ) | 703 052 $ | 30.09.2026 |
Aktive Positionen von Gabriel Brooks
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLID BIOSCIENCES INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2023 |
Ehemalige bekannte Positionen von Gabriel Brooks
| Unternehmen | Position | Ende |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2020 |
Ausbildung von Gabriel Brooks
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
